Mid Cap Most Volatile: Qunar Cayman Islands (NASDAQ:QUNR), Intercept Pharmaceuticals (NASDAQ:ICPT), Autohome (NYSE:ATHM), Puma Biotechnology (NYSE:PBYI)

Posted by on Mar 19, 2014

Aegis began coverage on shares of Qunar Cayman Islands Ltd (NASDAQ:QUNR) in a research note issued to investors on Thursday, TheFlyOnTheWall.com reports. The firm issued a hold rating and a $36.00 price target on the stock. Qunar Cayman Islands Ltd (NASDAQ:QUNR) shares after opening at $29.32 moved to $33.37 on last trade day and at the end of the day closed at $33.11. Company price to sales ratio in past twelve months was calculated as 27.67 and price to cash ratio as 42.27. Qunar Cayman Islands Ltd (NASDAQ:QUNR) showed a positive weekly performance of 5.38%.

Intercept Pharmaceuticals (NASDAQ:ICPT)‘s stock had its “buy” rating restated by Needham & Company in a research note issued on Monday, Stock Ratings Network reports. They currently have a $500.00 price target on the stock, up from their previous price target of $320.00. Needham & Company’s price target would indicate a potential upside of 22.80% from the company’s current price. Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) shares advanced 6.83% in last trading session and ended the day on $434.96. ICPT return on equity ratio is recorded as -103.20% and its return on assets is -63.70%. Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) yearly performance is 1092.32%.

Zacks began coverage on shares of Autohome (NASDAQ:ATHM) in a research note issued on Wednesday, Analyst Ratings Network.com reports. The firm set a “hold” rating on the stock. Autohome Inc. (ADR) (NYSE:ATHM) shares moved up 8.13% in last trading session and was closed at $45.24, while trading in range of $41.92 – $45.95. Autohome Inc. (ADR) (NYSE:ATHM) year to date (YTD) performance is 23.64%.

Puma Biotechnology, Inc. (NYSE:PBYI) a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at 11:45 a.m. EDT on Wednesday, March 19, at the Bank of America Merrill Lynch 2014 Smid Cap Conference. The conference will be held at The Ritz-Carlton, Boston Common. Puma Biotechnology Inc. (NYSE:PBYI) weekly performance is 11.59%. On last trading day company shares ended up $121.31. Puma Biotechnology Inc. (NYSE:PBYI) distance from 50-day simple moving average (SMA50) is 2.04%. Analysts mean target price for the company is $139.33.

Leave a Reply